亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Update οn the diagnosis and management of systemic lupus erythematosus

医学 风湿病 疾病 痹症科 重症监护医学 内科学
作者
Antonis Fanouriakis,Nikolaos Tziolos,George Βertsias,Dimitrios T. Boumpas
出处
期刊:Annals of the Rheumatic Diseases [BMJ]
卷期号:80 (1): 14-25 被引量:480
标识
DOI:10.1136/annrheumdis-2020-218272
摘要

Clinical heterogeneity, unpredictable course and flares are characteristics of systemic lupus erythematosus (SLE). Although SLE is—by and large—a systemic disease, occasionally it can be organ-dominant, posing diagnostic challenges. To date, diagnosis of SLE remains clinical with a few cases being negative for serologic tests. Diagnostic criteria are not available and classification criteria are often used for diagnosis, yet with significant caveats. Newer sets of criteria (European League Against Rheumatism (EULAR)/American College of Rheumatology (ACR) 2019) enable earlier and more accurate classification of SLE. Several disease endotypes have been recognised over the years. There is increased recognition of milder cases at presentation, but almost half of them progress overtime to more severe disease. Approximately 70% of patients follow a relapsing-remitting course, the remaining divided equally between a prolonged remission and a persistently active disease. Treatment goals include long-term patient survival, prevention of flares and organ damage, and optimisation of health-related quality of life. For organ-threatening or life-threatening SLE, treatment usually includes an initial period of high-intensity immunosuppressive therapy to control disease activity, followed by a longer period of less intensive therapy to consolidate response and prevent relapses. Management of disease-related and treatment-related comorbidities, especially infections and atherosclerosis, is of paramount importance. New disease-modifying conventional and biologic agents—used alone, in combination or sequentially—have improved rates of achieving both short-term and long-term treatment goals, including minimisation of glucocorticoid use.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
6秒前
张懒懒完成签到 ,获得积分10
8秒前
上官若男应助反方向的钟采纳,获得30
15秒前
27秒前
小二郎应助Ray羽曦~采纳,获得10
27秒前
xingxing完成签到,获得积分10
28秒前
30秒前
34秒前
萝卜大王发布了新的文献求助10
35秒前
36秒前
37秒前
39秒前
yshj完成签到 ,获得积分10
39秒前
de完成签到,获得积分10
39秒前
de发布了新的文献求助10
41秒前
42秒前
futianyu完成签到 ,获得积分10
43秒前
科目三应助科研通管家采纳,获得10
44秒前
44秒前
冷酷忆山发布了新的文献求助10
46秒前
萝卜大王关注了科研通微信公众号
50秒前
月亮完成签到 ,获得积分10
52秒前
反方向的钟完成签到,获得积分10
1分钟前
冷酷忆山完成签到 ,获得积分10
1分钟前
边曦完成签到 ,获得积分10
1分钟前
ronnie147完成签到 ,获得积分10
1分钟前
萝卜大王完成签到,获得积分10
1分钟前
1分钟前
阿司匹林发布了新的文献求助10
1分钟前
1分钟前
mm完成签到,获得积分10
2分钟前
潮人完成签到 ,获得积分10
2分钟前
Omni完成签到,获得积分10
2分钟前
有梦想的咸鱼完成签到,获得积分10
2分钟前
chenshi0515完成签到 ,获得积分10
2分钟前
2分钟前
Owen应助科研通管家采纳,获得10
2分钟前
SciGPT应助科研通管家采纳,获得10
2分钟前
在水一方应助科研通管家采纳,获得10
2分钟前
nini完成签到 ,获得积分10
2分钟前
高分求助中
Licensing Deals in Pharmaceuticals 2019-2024 3000
Effect of reactor temperature on FCC yield 2000
Very-high-order BVD Schemes Using β-variable THINC Method 1020
PraxisRatgeber: Mantiden: Faszinierende Lauerjäger 800
Mission to Mao: Us Intelligence and the Chinese Communists in World War II 600
The Conscience of the Party: Hu Yaobang, China’s Communist Reformer 600
MATLAB在传热学例题中的应用 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3303216
求助须知:如何正确求助?哪些是违规求助? 2937578
关于积分的说明 8482400
捐赠科研通 2611434
什么是DOI,文献DOI怎么找? 1425877
科研通“疑难数据库(出版商)”最低求助积分说明 662457
邀请新用户注册赠送积分活动 646980